BACK TO INDEX

Publications of N. Faucon Biguet
Articles in journal or book chapters
  1. O. Khalfallah, P. Ravassard, C. S. Lagache, C. Fligny, A. Serre, E. Bayard, N. Faucon-Biguet, J. Mallet, R. Meloni, and J. Nardelli. Zinc finger protein 191 (ZNF191/Zfp191) is necessary to maintain neural cells as cycling progenitors. Stem Cells, 27(7):1643-53, 2009. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW]


  2. O. Khalfallah, N. Faucon-Biguet, J. Nardelli, R. Meloni, and J. Mallet. Expression of the transcription factor Zfp191 during embryonic development in the mouse. Gene Expr Patterns, 8(3):148-154, 2008. Note: Journal article. [WWW]


  3. L. Amar, M. Desclaux, N. Faucon-Biguet, J. Mallet, and R. Vogel. Control of small inhibitory RNA levels and RNA interference by doxycycline induced activation of a minimal RNA polymerase III promoter. Nucleic Acids Res, 34(5):e37, 2006. Note: Journal ArticleResearch Support, Non-U.S. Gov'tEngland. [WWW] Keyword(s): Cell Line, Doxycycline/*pharmacology, Genetic Vectors, HIV-1/genetics, Humans, *Promoter Regions (Genetics), *RNA Interference, RNA Polymerase III/*metabolism, RNA, Small Interfering/biosynthesis/*genetics, *Trans-Activation (Genetics), Tumor Suppressor Protein p53/biosynthesis/genetics.


  4. M. Barkats, P. Horellou, P. Colin, S. Millecamps, N. Faucon-Biguet, and J. Mallet. 1-methyl-4-phenylpyridinium neurotoxicity is attenuated by adenoviral gene transfer of human Cu/Zn superoxide dismutase. J Neurosci Res, 83(2):233-42, 2006. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): 1-Methyl-4-phenylpyridinium/*toxicity, Animals, Cell Count/methods, Cell Line, Tumor, Disease Models, Animal, Female, Gene Therapy/*methods, Gene Transfer Techniques, Genetic Vectors/physiology, Humans, Immunohistochemistry/methods, Motor Activity/physiology, Neuroblastoma, Neurotoxicity Syndromes/*etiology/pathology/*therapy, Parkinson Disease/pathology/physiopathology/therapy, Rats, Rotarod Performance Test/methods, Substantia Nigra/metabolism/pathology, Superoxide Dismutase/*metabolism/*therapeutic use, Tetrazolium Salts/diagnostic use, Thiazoles/diagnostic use, Transgenes/physiology, Tyrosine 3-Monooxygenase/metabolism.


  5. M. J. Lecomte, S. De Gois, A. Guerci, P. Ravassard, N. Faucon Biguet, J. Mallet, and S. Berrard. Differential expression and regulation of the high-affinity choline transporter CHT1 and choline acetyltransferase in neurons of superior cervical ganglia. Mol Cell Neurosci, 28(2):303-13, 2005. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Acetylcholine/*biosynthesis, Animals, Animals, Newborn, Cation Transport Proteins/*genetics, Cell Differentiation/drug effects/*physiology, Cells, Cultured, Choline/metabolism, Choline O-Acetyltransferase/*genetics, Down-Regulation/drug effects/physiology, Gene Expression Regulation/drug effects/physiology, Interleukin-6/metabolism/pharmacology, Leukemia Inhibitory Factor, Neurons/cytology/drug effects/*metabolism, Norepinephrine/metabolism, Phenotype, RNA, Messenger/drug effects/metabolism, Rats, Rats, Wistar, Superior Cervical Ganglion/cytology/growth & development/*metabolism, Tretinoin/metabolism/pharmacology, Up-Regulation/drug effects/physiology.


  6. S. Brun, N. Faucon-Biguet, and J. Mallet. Optimization of transgene expression at the posttranscriptional level in neural cells: implications for gene therapy. Mol Ther, 7(6):782-9, 2003. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited Statesthe journal of the American Society of Gene Therapy. [WWW] Keyword(s): Adenoviridae/genetics, Animals, Cells, Cultured, Gene Expression Regulation, Viral, *Gene Therapy, Gene Transfer Techniques, Genetic Vectors, Humans, Lentivirus/*genetics, Luciferases/metabolism, Mice, Neurons/*metabolism, RNA Processing, Post-Transcriptional/*genetics, Rats, *Transgenes, Untranslated Regions/*genetics.


  7. P. Tejedor-Real, N. Faucon Biguet, S. Dumas, and J. Mallet. Tyrosine hydroxylase mRNA and protein are down-regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems. J Neurosci Res, 72(1):105-15, 2003. Note: Comparative StudyJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Animals, Clozapine/*administration & dosage, Corpus Striatum/*drug effects/enzymology, Down-Regulation/*drug effects/physiology, Gene Expression Regulation, Enzymologic/drug effects/physiology, Limbic System/drug effects/enzymology, Male, Proteins/metabolism, RNA, Messenger/metabolism, Rats, Rats, Sprague-Dawley, Substantia Nigra/*drug effects/enzymology, Tyrosine 3-Monooxygenase/*metabolism, Ventral Tegmental Area/*drug effects/enzymology.



BACK TO INDEX




Disclaimer:

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.




Last modified: Thu May 6 18:22:53 2010
Author: schwartz.


This document was translated from BibTEX by bibtex2html